3,574 research outputs found

    Foreword

    Get PDF

    Regulating Lethal Autonomous Robots In Unconventional Warfare

    Get PDF

    Consistent cooperation in a cichlid fish is caused by maternal and developmental effects rather than heritable genetic variation.

    Get PDF
    This is the author accepted manuscript. The final version is available from Royal Society via the DOI in this record.Studies on the evolution of cooperative behaviour are typically confined to understanding its adaptive value. It is equally essential, however, to understand its potential to evolve, requiring knowledge about the phenotypic consistency and genetic basis of cooperative behaviour. While previous observational studies reported considerably high heritabilities of helping behaviour in cooperatively breeding vertebrates, experimental studies disentangling the relevant genetic and non-genetic components of cooperative behaviour are lacking. In a half-sibling breeding experiment, we investigated the repeatability and heritability of three major helping behaviours performed by subordinates of the cooperatively breeding fishNeolamprologus pulcherTo experimentally manipulate the amount of help needed in a territory, we raised the fish in two environments differing in egg predation risk. All three helping behaviours were significantly repeatable, but had very low heritabilities. The high within-individual consistencies were predominantly due to maternal and permanent environment effects. The perceived egg predation risk had no effect on helping, but social interactions significantly influenced helping propensities. Our results reveal that developmentally plastic adjustments of provided help to social context shape cooperative phenotypes, whereas heritable genetic variation plays a minor role.Funding was provided by the ‘ProDoc’ program of the Swiss National Science Foundation (SNF, projects PDFMP3_137196 and 31003A_156881 to B.T.), and the ‘120% support grant’ to C.K. of the University of Bern

    Smartwatch aids time-based prospective memory in Korsakoff syndrome: A case study

    Get PDF
    Contains fulltext : 203608.pdf (publisher's version ) (Open Access)Prospective memory (PM) is the ability to remember to carry out an intention in the future. PM is particularly impaired in Korsakoff syndrome (KS). We investigated the benefit of a smartwatch and smartphone compared to no aid in supporting time accuracy and PM task performance in KS. Time accuracy was improved with a smartwatch compared to the other conditions. Furthermore, the smartwatch and phone conditions were more effective than no aid in assisting memory for task content. Together these results suggest that using an external memory aid is beneficial for successful PM in KS.5 p

    Nutrient and Microbial Movement from Seasonally-Used Septic Systems

    Get PDF
    Unanswered seasonal vacation communities present unique problems for on-site sewage disposal. Seasonal occupancy may promote the transmission of contaminants to groundwater due to incomplete formation of a biological clogging mat in the soil absorption system. Groundwater surrounding three seasonally-used septic systems was monitored to determine the movement and attenuation of nitrogen, phosphorus and two bacterial indicators of human fecal contamination, fecal coliforms and Clostridium perfringens. Nitrate-N concentrations were often three to four-fold greater than the drinking water standard at wells 6 m from the soil absorption systems. Minimal phosphorus migration occurred from these systems. Although more than 1.5 m of unsaturated soil separated the bottom of the soil absorption system from the groundwater, elevated numbers of both bacterial indicators were observed in groundwater at both 2 m and 6 m away from the absorption systems. Biological clogging mats, which are considered to be critical for even distribution of wastewater within a drainfield, were not ground when the systems were excavated at the end of summer occupancy. Siting seasonally-used shoreline septic systems may require improved effluent distribution to achieve wastewater renovation

    Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting

    Get PDF
    Background A recently conducted matching-adjusted indirect comparison demonstrated that bosutinib improved progression-free survival, and delayed progression to advanced disease compared with dasatinib and nilotinib in patients with second line (2L) chronic-phase chronic myeloid leukemia (CP-CML). However, the long-term clinical and economic impact of using bosutinib versus dasatinib and nilotinib has not been evaluated. The objective was to determine the cost-effectiveness of bosutinib compared with dasatinib and bosutinib compared with nilotinib from a US payer perspective. Methods A cost-effectiveness model was developed using partition survival methods and three health states: progression-free, progression, and death. Trial data (individual patient-level and aggregate-level data) informed the progression-free and overall survival estimates. Costs included drugs and medical resource use. Utility values were obtained from literature. Sensitivity analyses (SAs) included one-way and probabilistic sensitivity analyses (PSAs). Results Comparing bosutinib versus dasatinib resulted in a gain of 0.4 discounted life years, 1.5 quality-adjusted life years (QALYs), and incremental costs of 28,459(valuesin2020USdollars),foranincrementalcosteffectivenessratio(ICER)of28,459 (values in 2020 US dollars), for an incremental cost-effectiveness ratio (ICER) of 19,811/QALY gained. Comparing bosutinib versus nilotinib resulted in a gain of 0.8 discounted life-years, 1.8 QALYs, and incremental costs of 76,563,foranICERof76,563, for an ICER of 41,932/QALY gained. Drug costs and extrapolation distribution type were the main drivers of the model in the one-way SAs. In the PSAs, bosutinib had >90% and >80% probabilities of being cost-effective at a willingness-to-pay threshold of $100,000/QALY versus dasatinib and nilotinib, respectively. Conclusions Our results suggest that compared with dasatinib and nilotinib, bosutinib may represent good value for money for treating 2L CP-CML patients
    corecore